Sight Sciences touts positive study results of dry eye treatment device

Sight Sciences today announced positive results from a clinical trial of its TearCare wearable eyelid technology.

The Olympia study was a prospective, randomized multicenter trial that enrolled 235 dry eye patients across 10 sites in the U.S. The goal was to demonstrate the safety and effectiveness of a single TearCare procedure compared to the LipiFlow Thermal Pulsation System in treating signs and symptoms of dry eye disease.

Study results showed that a single TearCare treatment was able to safely and effectively achieve clinically meaningful improvements in all signs and symptoms of dry eye disease. Improvement in signs included tear break up time, meibomian gland secretion score and corneal and conjunctival staining. Symptom improvement included ocular surface disease index score, symptom assessment in dry eyes score and eye dryness score.

The company reported a significantly greater proportion of TearCare patients that had clinically meaning…

Read more
  • 0